Simplifying The Regulatory Submission Process With A Modern CTMS

Converging technologies in the clinical trials space are improving efficiencies on most fronts of the clinical research process. Gaps remain, however, and if we as an industry are to drive further efficiencies in clinical development, we must rethink our processes and our technology in a more modern context. Through direct work with a focus group composed of representatives from many divisions of the industry, the product development team at Fountayn reached the conclusion that regulatory submission, among other operations of interest, remained largely unassisted by the current ecosystem of clinical technology. Working in collaboration with industry representatives, this group explored the value that pulling the regulatory submission process into a modern Clinical Trial Management System (CTMS) could have, and devised a purpose-built solution to address that need.